LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 334

Search options

  1. Book ; Online ; E-Book: Geriatric neurology

    DeKosky, Steven T. / Asthana, Sanjay

    (Handbook of clinical neurology ; 167)

    2019  

    Author's details volume editors Steven T. DeKosky and Sanjay Asthana
    Series title Handbook of clinical neurology ; 167
    Collection
    Language English
    Size 1 Online-Ressource (xix, 601 Seiten), Illustrationen, Diagramme
    Publisher Elsevier
    Publishing place Amsterdam
    Publishing country Netherlands
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT020377460
    ISBN 978-0-12-805141-2 ; 9780128047668 ; 0-12-805141-8 ; 0128047666
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: The Broad Range of Research in Alzheimer's Disease and Related Dementias.

    DeKosky, Steven T / Duara, Ranjan

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

    2022  Volume 19, Issue 1, Page(s) 1–7

    MeSH term(s) Alzheimer Disease/therapy ; Dementia ; Humans
    Language English
    Publishing date 2022-05-13
    Publishing country United States
    Document type Editorial
    ZDB-ID 2316693-9
    ISSN 1878-7479 ; 1933-7213
    ISSN (online) 1878-7479
    ISSN 1933-7213
    DOI 10.1007/s13311-022-01245-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study.

    Wei, Yu-Jung Jenny / Shrestha, Nistha / Chiang, ChienWei / DeKosky, Steven T

    Alzheimer's research & therapy

    2024  Volume 16, Issue 1, Page(s) 30

    Abstract: Background: Limited data exist on the prevalence and trend of central nervous system (CNS)-active medication polypharmacy among adults with early-onset dementia (EOD) and whether these estimates differ for adults without EOD but with chronic pain, ... ...

    Abstract Background: Limited data exist on the prevalence and trend of central nervous system (CNS)-active medication polypharmacy among adults with early-onset dementia (EOD) and whether these estimates differ for adults without EOD but with chronic pain, depression, or epilepsy, conditions managed by CNS-active medications.
    Methods: A multi-year, cross-sectional study using 2012-2021 MarketScan Commercial Claims data was conducted among adults aged 30 to 64 years with EOD and those without EOD but having a diagnosis of chronic pain, depression, or epilepsy as comparison groups. For each disease cohort, the primary outcome was CNS-active medication polypharmacy defined as concurrent use of ≥ 3 CNS-active medications on the US Beers Criteria list that overlapped for > 30 consecutive days during 12 months following a randomly selected medical encounter with the disease diagnosis. A separate multivariate modified Poisson regression model was used to estimate time trends in CNS polypharmacy in each disease cohort. Differences in trend estimates between EOD and non-EOD disease cohorts were examined by an interaction between EOD status and yearly time.
    Results: From 2013 to 2020, the annual crude prevalence of CNS polypharmacy was higher among adults with EOD (21.2%-25.0%) than adults with chronic pain (5.1%-5.9%), depression (14.8%-21.7%), or epilepsy (20.0%-22.3%). The adjusted annual prevalence of CNS polypharmacy among patients with EOD did not significantly change between 2013 and 2020 (adjusted prevalence rate ratio [aPRR], 0.94; 95% CI, 0.88-1.01), whereas a significant decreasing trend was observed among non-EOD cohorts with chronic pain (aPRR, 0.66; 95% CI, 0.63-0.69), depression (aPRR, 0.81; 95% CI, 0.77-0.85), and epilepsy (aPRR, 0.86; 95% CI, 0.83-0.89). The interaction analysis indicated that patients with epilepsy and depression (vs with EOD) had a decreasing probability of CNS-active medication polypharmacy over time (aPRR, 0.98 [95% CI, 0.98-0.99]; P < .001 for interaction for both conditions).
    Conclusions: The prevalence of CNS polypharmacy among US commercially insured adults with EOD (vs without) was higher and remained unchanged from 2013 to 2021. Medication reviews of adults with EOD and CNS polypharmacy are needed to ensure that benefits outweigh risks associated with combined use of these treatments.
    MeSH term(s) Humans ; Adult ; Cross-Sectional Studies ; Polypharmacy ; Chronic Pain ; Prevalence ; Dementia/drug therapy ; Dementia/epidemiology ; Epilepsy/drug therapy ; Epilepsy/epidemiology ; Central Nervous System
    Language English
    Publishing date 2024-02-08
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2506521-X
    ISSN 1758-9193 ; 1758-9193
    ISSN (online) 1758-9193
    ISSN 1758-9193
    DOI 10.1186/s13195-024-01405-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Dementia

    DeKosky, Steven T.

    (Neurologic clinics ; 18,4)

    2000  

    Author's details Steven T. DeKosky, guest ed
    Series title Neurologic clinics ; 18,4
    Collection
    Language English
    Size X S., S. 773 - 1044 : Ill., graph. Darst.
    Publisher Saunders
    Publishing place Philadelphia u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT012887729
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Book ; Conference proceedings: Cornerstones in the management of Alzheimer's disease

    DeKosky, Steven T.

    CME accredited symposium at World Alzheimer Congress (WAC) 2000 Meeting, 9 - 18 July 2000, Washington DC, USA

    (Alzheimer disease and associated disorders ; 15, Suppl. 1)

    2001  

    Event/congress World Alzheimer Congress (2000, WashingtonDC)
    Author's details guest ed.: Steven T. DeKosky
    Series title Alzheimer disease and associated disorders ; 15, Suppl. 1
    Alzheimer disease & associated disorders
    Collection Alzheimer disease & associated disorders
    Language English
    Size S40 S. : Ill., graph. Darst.
    Publisher Lippincott Williams & Wilkins
    Publishing place Philadelphia
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT013146360
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Book: Managing Alzheimer's disease

    DeKosky, Steven T.

    (Neurology ; 48, Suppl. 6)

    1997  

    Author's details Steven T. DeKosky, suppl. ed
    Series title Neurology ; 48, Suppl. 6
    Collection
    Keywords Alzheimer Disease
    Language English
    Size S41 S.
    Publisher Lippincott-Raven
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT007592135
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  7. Article ; Online: Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer's disease and related dementia.

    Wei, Yu-Jung Jenny / Winterstein, Almut G / Schmidt, Siegfried / Fillingim, Roger B / Schmidt, Stephan / Daniels, Michael J / DeKosky, Steven T

    Age and ageing

    2024  Volume 53, Issue 3

    Abstract: Background: Limited evidence exists on the short- and long-term safety of discontinuing versus continuing chronic opioid therapy (COT) among patients with Alzheimer's disease and related dementias (ADRD).: Methods: This cohort study was conducted ... ...

    Abstract Background: Limited evidence exists on the short- and long-term safety of discontinuing versus continuing chronic opioid therapy (COT) among patients with Alzheimer's disease and related dementias (ADRD).
    Methods: This cohort study was conducted among 162,677 older residents with ADRD and receipt of COT using a 100% Medicare nursing home sample. Discontinuation of COT was defined as no opioid refills for ≥90 days. Primary outcomes were rates of pain-related hospitalisation, pain-related emergency department visit, injury, opioid use disorder (OUD) and opioid overdose (OD) measured by diagnosis codes at quarterly intervals during 1- and 2-year follow-ups. Poisson regression models were fit using generalised estimating equations with inverse probability of treatment weights to model quarterly outcome rates between residents who discontinued versus continued COT.
    Results: The study sample consisted of 218,040 resident episodes with COT; of these episodes, 180,916 residents (83%) continued COT, whereas 37,124 residents (17%) subsequently discontinued COT. Discontinuing (vs. continuing) COT was associated with higher rates of all outcomes in the first quarter, but these associations attenuated over time. The adjusted rates of injury, OUD and OD were 0, 69 and 60% lower at the 1-year follow-up and 11, 81 and 79% lower at the 2-year follow-up, respectively, for residents who discontinued versus continued COT, with no difference in the adjusted rates of pain-related hospitalisations or emergency department visits.
    Conclusions: The rates of adverse outcomes were higher in the first quarter but lower or non-differential at 1-year and 2-year follow-ups between COT discontinuers versus continuers among older residents with ADRD.
    MeSH term(s) Humans ; Aged ; United States/epidemiology ; Analgesics, Opioid/adverse effects ; Cohort Studies ; Alzheimer Disease/diagnosis ; Alzheimer Disease/drug therapy ; Alzheimer Disease/epidemiology ; Medicare ; Opioid-Related Disorders/drug therapy ; Pain/drug therapy ; Retrospective Studies
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2024-03-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 186788-x
    ISSN 1468-2834 ; 0002-0729
    ISSN (online) 1468-2834
    ISSN 0002-0729
    DOI 10.1093/ageing/afae047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.

    Nagaraja, Nandakumar / Wang, Wei-En / Duara, Ranjan / DeKosky, Steven T / Vaillancourt, David

    Journal of Alzheimer's disease : JAD

    2023  Volume 93, Issue 2, Page(s) 495–507

    Abstract: Background: Hippocampal atrophy in cerebral amyloid angiopathy (CAA) has been reported to be similar to that in Alzheimer's disease (AD).: Objective: To evaluate if CAA pathology partly mediates reduced hippocampal volume in patients with AD.: ... ...

    Abstract Background: Hippocampal atrophy in cerebral amyloid angiopathy (CAA) has been reported to be similar to that in Alzheimer's disease (AD).
    Objective: To evaluate if CAA pathology partly mediates reduced hippocampal volume in patients with AD.
    Methods: Patients with a clinical diagnosis of AD and neuropathological confirmation of AD+/-CAA in the National Alzheimer's Coordinating Center database were included in the study. The volumes of temporal lobe structures were calculated on T1-weighted imaging (T1-MRI) using automated FreeSurfer software, from images acquired on average 5 years prior to death. Multivariate regression analysis was performed to compare brain volumes in four CAA groups. The hippocampal volume on T1-MRI was correlated with Clinical Dementia Rating sum of boxes (CDRsb) score, apolipoprotein E (APOE) genotype, and hippocampal atrophy at autopsy.
    Results: The study included 231 patients with no (n = 45), mild (n = 70), moderate (n = 67), and severe (n = 49) CAA. Among the four CAA groups, patients with severe CAA had a smaller mean left hippocampal volume (p = 0.023) but this was not significant when adjusted for APOE ɛ4 (p = 0.07). The left hippocampal volume on MRI correlated significantly with the hippocampal atrophy grading on neuropathology (p = 0.0003). Among patients with severe CAA, the left hippocampal volume on T1-MRI: (a) decreased with an increase in the number of APOE ɛ4 alleles (p = 0.04); but (b) had no evidence of correlation with CDRsb score (p = 0.57).
    Conclusion: Severe CAA was associated with smaller left hippocampal volume on T1-MRI up to five years prior to death among patients with neuropathologically confirmed AD. This relationship was dependent on APOE ɛ4 genotype.
    MeSH term(s) Humans ; Alzheimer Disease/diagnostic imaging ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Cerebral Amyloid Angiopathy/diagnostic imaging ; Cerebral Amyloid Angiopathy/genetics ; Cerebral Amyloid Angiopathy/pathology ; Apolipoproteins E/genetics ; Apolipoprotein E4/genetics ; Hippocampus/diagnostic imaging ; Hippocampus/pathology
    Chemical Substances Apolipoproteins E ; Apolipoprotein E4
    Language English
    Publishing date 2023-04-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-220624
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature.

    Walker, Ariel / Chapin, Ben / Abisambra, Jose / DeKosky, Steven T

    Acta neuropathologica communications

    2022  Volume 10, Issue 1, Page(s) 13

    Abstract: Background: The initiation, anatomic pattern, and extent of tau spread in traumatic brain injury (TBI), and the mechanism by which TBI leads to long-term tau pathology, remain controversial. Some studies suggest that moderate to severe TBI is sufficient ...

    Abstract Background: The initiation, anatomic pattern, and extent of tau spread in traumatic brain injury (TBI), and the mechanism by which TBI leads to long-term tau pathology, remain controversial. Some studies suggest that moderate to severe TBI is sufficient to promote tau pathology; however, others suggest that it is simply a consequence of aging. We therefore conducted a systematic narrative review of the literature addressing whether a single moderate to severe head injury leads to long-term development of tauopathy in both humans and animal models.
    Methods: Studies considered for inclusion in this review assessed a single moderate to severe TBI, assessed tau pathology at long-term timepoints post-injury, comprised experimental or observational studies, and were peer-reviewed and published in English. Databases searched included: PUBMED, NCBI-PMC, EMBASE, Web of Science, Academic Search Premiere, and APA Psychnet. Search results were uploaded to Covidence®, duplicates were removed, and articles underwent an abstract and full-text screening process. Data were then extracted and articles assessed for risk of bias.
    Findings: Of 4,150 studies screened, 26 were eligible for inclusion, of which 17 were human studies, 8 were preclinical animal studies, and 1 included both human and preclinical animal studies. Most studies had low to moderate risk of bias. Most human and animal studies (n = 12 and 9, respectively) suggested that a single moderate to severe TBI resulted in greater development of long-term tauopathy compared to no history of head injury. This conclusion should be interpreted with caution, however, due to several limitations: small sample sizes; inconsistencies in controlling for confounding factors that may have affected tau pathology (e.g., family history of dementia or neurological illnesses, apolipoprotein E genotype, etc.), inclusion of mostly males, and variation in reporting injury parameters.
    Interpretation: Results indicate that a single moderate to severe TBI leads to greater chronic development of tauopathy compared to no history of head injury. This implies that tau pathology induced may not be transient, but can progressively develop over time in both humans and animal models. Targeting these tau changes for therapeutic intervention should be further explored to elucidate if disease progression can be reversed or mitigated.
    MeSH term(s) Animals ; Brain/pathology ; Brain Injuries, Traumatic/complications ; Brain Injuries, Traumatic/pathology ; Disease Models, Animal ; Humans ; Tauopathies/etiology ; Tauopathies/pathology
    Language English
    Publishing date 2022-01-31
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Systematic Review
    ZDB-ID 2715589-4
    ISSN 2051-5960 ; 2051-5960
    ISSN (online) 2051-5960
    ISSN 2051-5960
    DOI 10.1186/s40478-022-01311-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Examining the relationship between anxiety and regional brain volumes in the National Alzheimer's Coordinating Center uniform, imaging, and biomarker datasets.

    Burke, Shanna L / Grudzien, Adrienne / Li, Tan / Abril, Marlou / Yin, Wupeng / Tyrell, Tahirah A / Barnes, Christopher P / Hanson, Kevin / DeKosky, Steven T

    Cerebral circulation - cognition and behavior

    2024  Volume 6, Page(s) 100201

    Abstract: Anxiety has been associated with a greater risk of Alzheimer's disease (AD). Existing research has identified structural differences in regional brain tissue in participants with anxiety, but results have been inconsistent. We sought to determine the ... ...

    Abstract Anxiety has been associated with a greater risk of Alzheimer's disease (AD). Existing research has identified structural differences in regional brain tissue in participants with anxiety, but results have been inconsistent. We sought to determine the association between anxiety and regional brain volumes, and the moderation effect of APOE ε4. Using data from participants in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set, with complete imaging (MRI) and biomarker data (
    Language English
    Publishing date 2024-01-16
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2666-2450
    ISSN (online) 2666-2450
    DOI 10.1016/j.cccb.2024.100201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top